Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

Funding US-based microbiome therapy developer Vedanta Biosciences completed a $68m series D round yesterday that included a $25m investment from pharmaceutical firm Pfizer and additional cash from synthetic rubber producer JSR Corporation, healthcare services provider SymBiosis and Fosun Health Capital, a vehicle for conglomerate Fosun. Affiliates of Magnetar Capital led the round, which also featured…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.